CHATSWORTH, Calif.--(BUSINESS WIRE)--North American Scientific, Inc. (Nasdaq: NASM) today announced financial results for its fiscal second quarter ended April 30, 2008. For the second quarter of fiscal 2008, the Company reported revenues from continuing operations of approximately $4.6 million, an 22% increase over the second quarter of the prior year, and a net loss from continuing operations of $4.3 million, or $0.05 per share, compared to the net loss from continuing operations for the second quarter of the prior fiscal year of $2.1 million, or $0.07 per share. Continuing operations exclude the discontinued operations of the NOMOS® Radiation Oncology business which was sold in September, 2007, Per share results are based on shares outstanding April 30, 2008, immediately prior to the 1-for-5 reverse split approved by the shareholders and implemented on May 1, 2008.
